Drugs / DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine
DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine
also known as
DTP-HB-Hib Vaccine (Bio Farma)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05482282 | Dec 2025 → Dec 2026 | hepatitis B virus infection | PT Bio Farma | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05482282 ↗ |
| Known as | DTP-HB-Hib Vaccine (Bio Farma) | “evaluate protectivity of DTP-HB-Hib Vaccine (Bio Farma) using new Hepatitis B bulk (Bio Farma)” NCT05482282 ↗ |
| Modality | Vaccine | “DTP-HB-Hib Vaccine (Bio Farma)” NCT05482282 ↗ |